标题
Echinocandin Resistance in Candida Species: a Review of Recent Developments
作者
关键词
Anidulafungin, Caspofungin, Micafungin, <em class=EmphasisTypeItalic >Candida</em>, <em class=EmphasisTypeItalic >Candida glabrata</em>, <em class=EmphasisTypeItalic >FKS1</em>, <em class=EmphasisTypeItalic >FKS2</em>, Antifungal resistance, Echinocandin resistance
出版物
Current Infectious Disease Reports
Volume 18, Issue 12, Pages -
出版商
Springer Nature
发表日期
2016-10-22
DOI
10.1007/s11908-016-0549-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rapid Detection ofFKS-Associated Echinocandin Resistance in Candida glabrata
- (2016) Yanan Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2016) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Effects of Treated versus Untreated Polystyrene on CaspofunginIn VitroActivity against Candida Species
- (2016) Annette W. Fothergill et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
- (2016) Kelley R. Healey et al. Nature Communications
- Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study
- (2015) R. H. Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Risk Factors for Echinocandin NonsusceptibleCandida glabrataBloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014
- (2015) Snigdha Vallabhaneni et al. Open Forum Infectious Diseases
- Positions and Numbers ofFKSMutations in Candida albicans Selectively InfluenceIn VitroandIn VivoSusceptibilities to Echinocandin Treatment
- (2014) M. Lackner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates
- (2014) Gregory A. Eschenauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin Failure Case Due to a Previously UnreportedFKS1Mutation in Candida krusei
- (2014) Rasmus Hare Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
- (2014) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
- (2014) N. D. Beyda et al. CLINICAL INFECTIOUS DISEASES
- Echinocandin resistance
- (2014) Maiken C. Arendrup et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria
- (2014) Michael A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
- (2013) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin
- (2013) A. Fekkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for IdentifyingFKSMutant Candida glabrata Strains and Echinocandin Resistance
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stepwise Development of a Homozygous S80P Substitution in Fks1p, Conferring Echinocandin Resistance in Candida tropicalis
- (2012) Rasmus Hare Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS
- (2012) O. Lortholary et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
- (2012) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
- (2012) Sheena D. Singh-Babak et al. PLoS Pathogens
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin Susceptibility Testing ofCandidaspp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots
- (2011) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on anidulafungin
- (2011) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)
- (2011) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now